{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:45:18Z","timestamp":1788191118887,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2025SF-YBXM-490"],"award-info":[{"award-number":["2025SF-YBXM-490"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200974"],"award-info":[{"award-number":["32200974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200420"],"award-info":[{"award-number":["82200420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117697","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:09:41Z","timestamp":1767917381000},"page":"117697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in understanding the pathogenesis, diagnosis, and treatment of tuberous sclerosis complex (TSC)-associated Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3367-3378","authenticated-orcid":false,"given":"Zhongchao","family":"Gai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2026.117697_b0005","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","article-title":"Updated prevalence of lymphangioleiomyomatosis in Europe","volume":"209","author":"Lynn","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1378\/chest.12-2813","article-title":"Lymphangioleiomyomatosis screening in women with tuberous sclerosis","volume":"144","author":"Cudzilo","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.bcp.2026.117697_b0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1513\/AnnalsATS.202008-911OC","article-title":"Lymphangioleiomyomatosis association with underlying genotype in patients with tuberous sclerosis complex","volume":"18","author":"Tian","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"9","key":"10.1016\/j.bcp.2026.117697_b0025","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/modpathol.2017.52","article-title":"Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story","volume":"30","author":"Murphy","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcp.2026.117697_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","article-title":"Advances and future directions for tuberous sclerosis complex research: recommendations from the 2015 strategic planning conference","volume":"60","author":"Sahin","year":"2016","journal-title":"Pediatr. Neurol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117697_b0035","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","article-title":"mTOR substrate phosphorylation in growth control","volume":"185","author":"Battaglioni","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0040","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172116","article-title":"Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling","volume":"134","author":"Lin","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0045","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad061","article-title":"Estradiol augments tumor-induced neutrophil production to promote tumor cell actions in lymphangioleiomyomatosis models","volume":"164","author":"Minor","year":"2023","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/ERC-15-0505","article-title":"Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model","volume":"23","author":"Prizant","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bcp.2026.117697_b0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2015.12.008","article-title":"Lymphangioleiomyomatosis: current understanding and potential treatments","volume":"158","author":"Moir","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117697_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9820181","article-title":"Recent advances and challenges of mTOR inhibitors use in the treatment of patients with tuberous sclerosis complex","volume":"2017","author":"Palavra","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajmg.c.31638","article-title":"Pulmonary manifestations in tuberous sclerosis complex","volume":"178","author":"Gupta","year":"2018","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166743","article-title":"Architecture of the tuberous sclerosis protein complex","volume":"433","author":"Ramlaul","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41467-020-20522-4","article-title":"Structural insights into TSC complex assembly and GAP activity on Rheb","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.bcp.2026.117697_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5807","article-title":"Structure of the human TSC:WIPI3 lysosomal recruitment complex","volume":"10","author":"Bayly-Jones","year":"2024","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.bcp.2026.117697_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/genes15111432","article-title":"Molecular and functional assessment of TSC1 and TSC2 in individuals with tuberous sclerosis complex","volume":"15","author":"Dufner-Almeida","year":"2024","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00438-024-02210-w","article-title":"Analysis of TSC1 and TSC2 genes and evaluation of phenotypic correlations with tuberous sclerosis","volume":"300","author":"Eser","year":"2024","journal-title":"Mol. Genet. Genomics"},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farcas","year":"2022","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117697_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226400","article-title":"Mutation spectrums of TSC1 and TSC2 in chinese women with lymphangioleiomyomatosis (LAM)","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2026.117697_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.70017","article-title":"Deep sequencing and phenotyping in an australian tuberous sclerosis complex \u201cno mutations identified\u201d cohort","volume":"12","author":"Chung","year":"2024","journal-title":"Mol. Genet. Genomic Med."},{"issue":"7685","key":"10.1016\/j.bcp.2026.117697_b0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature25023","article-title":"Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40","volume":"552","author":"Yang","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117697_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002954","article-title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2\/mTORC1\/p62 axis in tumor-infiltrating CD8T lymphocytes","volume":"9","author":"Nishida","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.bcp.2026.117697_b0125","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/s41388-018-0625-1","article-title":"Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target","volume":"38","author":"Abdelwahab","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0130","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1038\/s41598-021-88064-3","article-title":"Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis","volume":"11","author":"Nishino","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117697_b0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2021.03.094","article-title":"Propofol inhibits tumor angiogenesis through targeting VEGF\/VEGFR and mTOR\/eIF4E signaling","volume":"555","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2026.117697_b0140","doi-asserted-by":"crossref","first-page":"e1333","DOI":"10.1002\/ctm2.1333","article-title":"Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibiting Bim-mediated apoptosis via COX2\/PGE2\/ERK pathway","volume":"13","author":"Feng","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117697_b0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-22-0224","article-title":"Tyrosine kinase inhibitors diminish renal neoplasms in a tuberous sclerosis model via induction of apoptosis","volume":"22","author":"Unachukwu","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.117697_b0150","doi-asserted-by":"crossref","first-page":"14534","DOI":"10.1038\/srep14534","article-title":"PAK2 is an effector of TSC1\/2 signaling independent of mTOR and a potential therapeutic target for tuberous sclerosis complex","volume":"5","author":"Alves","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2026.117697_b0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41419-022-05511-3","article-title":"Targeting SPHK1\/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-024-03239-1","article-title":"Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis","volume":"19","author":"Tai","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"S01","key":"10.1016\/j.bcp.2026.117697_b0165","first-page":"e1508","article-title":"Systematic review of lymphangioleiomyomatosis outcomes in pregnancy and a proposed management guideline","volume":"41","author":"Champion","year":"2024","journal-title":"Am. J. Perinatol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117697_b0170","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/thoraxjnl-2020-214987","article-title":"Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts","volume":"75","author":"Taveira-DaSilva","year":"2020","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-014-1559-9","article-title":"In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor","volume":"464","author":"Gao","year":"2014","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/crj.13108","article-title":"Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center","volume":"14","author":"Kurosaki","year":"2020","journal-title":"Clin. Respir. J."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.healun.2022.09.021","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"42","author":"Warrior","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5500\/wjt.v6.i1.249","article-title":"Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation","volume":"6","author":"Zaki","year":"2016","journal-title":"World J. Transplant."},{"issue":"10","key":"10.1016\/j.bcp.2026.117697_b0195","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","article-title":"Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell","volume":"202","author":"Guo","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0200","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1038\/s41467-020-18979-4","article-title":"mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline","volume":"11","author":"Obraztsova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117697_b0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijscr.2017.10.057","article-title":"An extrapulmonary manifestation of lymphangioleiomyomatosis: a rare case report","volume":"41","author":"Tumay","year":"2017","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.bcp.2026.117697_b0210","article-title":"Lymphangioleiomyomatosis: a review","author":"Bouanzoul","year":"2024","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117697_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110265","article-title":"Circulating biomarkers of kidney angiomyolipoma and cysts in tuberous sclerosis complex patients","volume":"27","author":"Rubtsova","year":"2024","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.bcp.2026.117697_b0220","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/en.2016-1395","article-title":"Minireview: lymphangioleiomyomatosis (LAM): the \u201cother\u201d steroid-sensitive cancer","volume":"157","author":"Prizant","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0225","article-title":"Lymphangioleiomyomatosis: a clinical review","volume":"16","author":"O'Mahony","year":"2020","journal-title":"Breathe (Sheff.)"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2022.100194","article-title":"Chylothorax, in the spotlight of lymphangioleiomyomatosis","volume":"4","author":"Gamez-Baeza","year":"2022","journal-title":"Open Respir Arch."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12890-023-02837-2","article-title":"Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis","volume":"24","author":"Mendonca","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bcp.2026.117697_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2015.11.002","article-title":"Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses","volume":"50","author":"Hayashi","year":"2016","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/qjmed\/hcy215","article-title":"The UK guidelines for management and surveillance of tuberous sclerosis complex","volume":"112","author":"Amin","year":"2019","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17476348.2018.1409622","article-title":"Emerging biomarkers of lymphangioleiomyomatosis","volume":"12","author":"Nijmeh","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0255","first-page":"140","article-title":"Diagnostic and treatment monitoring potential of serum vascular endothelial growth factor-D in lymphangioleiomyomatosis","volume":"49","author":"Mou","year":"2016","journal-title":"Lymphology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2023.02.026","article-title":"Determinants of progression and mortality in lymphangioleiomyomatosis","volume":"164","author":"Xu","year":"2023","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0265","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/0008-5472.CAN-16-2755","article-title":"Aberrant SYK kinase signaling is essential for tumorigenesis induced by TSC2 inactivation","volume":"77","author":"Cui","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117697_b0270","article-title":"Exploring the role of matrix metalloproteinases as biomarkers in sporadic lymphangioleiomyomatosis and tuberous sclerosis complex. a pilot study","volume":"8","author":"Terraneo","year":"2021","journal-title":"Front Med (lausanne)"},{"issue":"7","key":"10.1016\/j.bcp.2026.117697_b0275","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jnen\/nlaa040","article-title":"Dysregulation of the MMP\/TIMP proteolytic system in subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: modulation of MMP by MicroRNA-320d in vitro","volume":"79","author":"Bongaarts","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/nan.12572","article-title":"Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147b in vitro","volume":"46","author":"Broekaart","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"41","key":"10.1016\/j.bcp.2026.117697_b0285","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/s41388-022-02443-2","article-title":"GPNMB: a potent inducer of immunosuppression in cancer","volume":"41","author":"Lazaratos","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-023-05608-3","article-title":"CCN3\/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer","volume":"14","author":"Son","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0295","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0312","article-title":"Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis","volume":"31","author":"Gibbons","year":"2024","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cjp2.162","article-title":"Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response","volume":"6","author":"Miller","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0305","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/CJI.0000000000000374","article-title":"PMEL as a prognostic biomarker and negatively associated with immune infiltration in skin cutaneous melanoma (SKCM)","volume":"44","author":"Zhang","year":"2021","journal-title":"J. Immunother."},{"issue":"10","key":"10.1016\/j.bcp.2026.117697_b0310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124405","article-title":"An effective mouse model for adoptive cancer immunotherapy targeting neoantigens","volume":"4","author":"Hanada","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0315","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI93303","article-title":"Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy","volume":"128","author":"Hailemichael","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CMR.0000000000000796","article-title":"Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients","volume":"32","author":"Wach","year":"2022","journal-title":"Melanoma Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0325","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2018","article-title":"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis","volume":"53","author":"Gupta","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0330","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13023-021-02081-z","article-title":"Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis","volume":"16","author":"Sakurai","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9869","key":"10.1016\/j.bcp.2026.117697_b0335","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bcp.2026.117697_b0345","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/bcp.12834","article-title":"Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"81","author":"Budde","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117697_b0350","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2017.01.014","article-title":"A kinase inhibitor targeted to mTORC1 drives regression in glioblastoma","volume":"31","author":"Fan","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.117697_b0355","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/cas.14395","article-title":"Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma","volume":"111","author":"Kuroshima","year":"2020","journal-title":"Cancer Sci."},{"issue":"7928","key":"10.1016\/j.bcp.2026.117697_b0360","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41586-022-05213-y","article-title":"Brain-restricted mTOR inhibition with binary pharmacology","volume":"609","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thoraxjnl-2017-210872","article-title":"Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study","volume":"73","author":"Bee","year":"2018","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0370","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic society\/japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.117697_b0375","doi-asserted-by":"crossref","first-page":"E944","DOI":"10.1073\/pnas.1719960115","article-title":"Effect of beta-agonists on LAM progression and treatment","volume":"115","author":"Le","year":"2018","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2026.117697_b0380","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/thoraxjnl-2019-213338","article-title":"Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use","volume":"74","author":"Johnson","year":"2019","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0385","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00408-017-0016-3","article-title":"Metabolic impact of rapamycin (Sirolimus) and B-estradiol using mouse embryonic fibroblasts as a model for lymphangioleiomyomatosis","volume":"195","author":"Marsh","year":"2017","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.bcp.2026.117697_b0390","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jog.13822","article-title":"A case of uterine lymphangioleiomyomatosis in a young woman that was identified via peritonitis","volume":"45","author":"Yoshizawa","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0395","article-title":"Brazilian thoracic association recommendations for the management of lymphangioleiomyomatosis","volume":"51","author":"Baldi","year":"2025","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.bcp.2026.117697_b0400","article-title":"French recommendations for the diagnosis and management of lymphangioleiomyomatosis","volume":"83","author":"Cottin","year":"2023","journal-title":"Respir. Med Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.117697_b0405","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.trecan.2024.06.003","article-title":"Next-generation cancer vaccines and emerging immunotherapy combinations","volume":"10","author":"Brandenburg","year":"2024","journal-title":"Trends Cancer."},{"issue":"8","key":"10.1016\/j.bcp.2026.117697_b0410","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98674","article-title":"TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1\/anti-CTLA-4 immunotherapy","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0415","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2018-0123OC","article-title":"Immune checkpoint ligand PD-L1 is upregulated in pulmonary lymphangioleiomyomatosis","volume":"59","author":"Maisel","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0420","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117697_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1352805","article-title":"Adoptive T cell therapy for solid tumors: current landscape and future challenges","volume":"15","author":"Albarran","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1165\/rcmb.2019-0117OC","article-title":"Adoptive T-cell transfer to treat lymphangioleiomyomatosis","volume":"62","author":"Han","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117697_b0435","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1165\/rcmb.2023-0410OC","article-title":"Plasmacytoid dendritic cells mediate CpG-ODN-induced increase in survival in a mouse model of lymphangioleiomyomatosis","volume":"71","author":"Amosu","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1517\/21678707.2016.1148597","article-title":"Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis","volume":"4","author":"Taveira-DaSilva","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"4","key":"10.1016\/j.bcp.2026.117697_b0445","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jtcvs.2024.08.038","article-title":"Surgical management of pleural complications in lymphangioleiomyomatosis","volume":"169","author":"Stanifer","year":"2025","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.bcp.2026.117697_b0450","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atssr.2024.07.011","article-title":"Lung transplantation outcomes and peritransplant sirolimus use in lymphangioleiomyomatosis","volume":"3","author":"Larson","year":"2025","journal-title":"Ann. .thorac. Surg. Short Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.117697_b0455","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00408-017-0045-y","article-title":"Experience of lung transplantation in patients with lymphangioleiomyomatosis at a brazilian reference centre","volume":"195","author":"Baldi","year":"2017","journal-title":"Lung"},{"issue":"393","key":"10.1016\/j.bcp.2026.117697_b0460","doi-asserted-by":"crossref","first-page":"rs9","DOI":"10.1126\/scisignal.aab3729","article-title":"Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi","volume":"8","author":"Housden","year":"2015","journal-title":"Sci. Signal."},{"issue":"8","key":"10.1016\/j.bcp.2026.117697_b0465","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"PNAS"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:43:12Z","timestamp":1778056992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":93,"alternative-id":["S0006295226000286"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117697","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in understanding the pathogenesis, diagnosis, and treatment of tuberous sclerosis complex (TSC)-associated Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117697"}}